دورية أكاديمية

Ruxolitinib discontinuation syndrome: incidence, risk factors, and management in 251 patients with myelofibrosis

التفاصيل البيبلوغرافية
العنوان: Ruxolitinib discontinuation syndrome: incidence, risk factors, and management in 251 patients with myelofibrosis
المؤلفون: Francesca Palandri, Giuseppe Alberto Palumbo, Elena Maria Elli, Nicola Polverelli, Giulia Benevolo, Bruno Martino, Elisabetta Abruzzese, Mario Tiribelli, Alessia Tieghi, Roberto Latagliata, Francesco Cavazzini, Micaela Bergamaschi, Gianni Binotto, Monica Crugnola, Alessandro Isidori, Giovanni Caocci, Florian Heidel, Novella Pugliese, Costanza Bosi, Daniela Bartoletti, Giuseppe Auteri, Daniele Cattaneo, Luigi Scaffidi, Malgorzata Monica Trawinska, Rossella Stella, Fiorella Ciantia, Fabrizio Pane, Antonio Cuneo, Mauro Krampera, Gianpietro Semenzato, Roberto Massimo Lemoli, Alessandra Iurlo, Nicola Vianelli, Michele Cavo, Massimo Breccia, Massimiliano Bonifacio
المصدر: Blood Cancer Journal, Vol 11, Iss 1, Pp 1-4 (2021)
بيانات النشر: Nature Publishing Group, 2021.
سنة النشر: 2021
المجموعة: LCC:Neoplasms. Tumors. Oncology. Including cancer and carcinogens
مصطلحات موضوعية: Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
نوع الوثيقة: article
وصف الملف: electronic resource
اللغة: English
تدمد: 2044-5385
العلاقة: https://doaj.org/toc/2044-5385Test
DOI: 10.1038/s41408-020-00392-1
الوصول الحر: https://doaj.org/article/1a0e0feee4a847eb9105d5df87c25b48Test
رقم الانضمام: edsdoj.1a0e0feee4a847eb9105d5df87c25b48
قاعدة البيانات: Directory of Open Access Journals
الوصف
تدمد:20445385
DOI:10.1038/s41408-020-00392-1